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Introduction:
Inflammatory bowel disease (IBD) is a chronic inflammatory 
condition of unknown etiology that is thought to result from 
a complex interaction of genetic predisposition (leading to 
immunological abnormalities), dysbiosis of the gut microbi-
ota, and environmental influences. However, none of the risk 
factors alone were sufficient for disease development, but the 
complex interactions between each factor play a major role 
leading to the development of IBD.1 These risk factors alone or 
in combination may play a significant role in the development 
of IBD.2 The incidence of IBD has been increasing in both 
developing and developed nations and this is hypothesized to 
be in part related to the change in dietary and lifestyle factors 
associated with modernization.3 Huang et al. (2016) found 
that abnormal innate immune responses may induce adaptive 
immunity imbalance, where inflammatory cytokines pro-
duced may increase innate immune damages, abate intestinal 
barrier functions, and aggravate inflammation.4 Additionally, 
an immunological imbalance of the intestinal mucosa, mainly 
associated with cells of the adaptive immune system, which 
responds against self-antigens, produces chronic inflamma-
tory conditions in these patients, and it is thought that aber-
rant and continuing immune response to the microbes in the 
gut, catalyzed by genetic susceptibility of the individual, main-
tains ongoing intestinal mucosal inflammation.5 Subsequently, 
this ongoing inflammation damages the intestinal wall, lead-
ing to diarrhea, bleeding and abdominal pain.6 Fig. 1 shows 
the complex pathogenesis of IBDs.3
IBD has an increasing incidence and prevalence in most 
countries and becomes a global emerging disease.3 A west-
ernized lifestyle, personal habits, and environmental factors 
have been found to contribute to the pathogenesis of IBD.7 
The relevant risk factors (including smoking, hygiene hypoth-
esis, microorganisms, appendectomy, medication, nutrition, 
and stress) have all been associated with the pathogenesis of 
IBD.8 However, the exact specific mechanism underlying the 
association between environmental factors and IBD is still 
poorly understood.6 The treatment of IBD in any given patient 
may have several different goals, such as relief of symptoms: 
abdominal pain, rectal bleeding, and diarrhea; induction 
of remission in patients with active disease; prevention of 
relapse; correction of nutritional deficiencies; healing of fistu-
las; and avoidance of emergency surgery with the ultimate goal 
of improving quality of life.9 The current drug therapy includ-
ing the use of anti-inflammatory agents and immunomodula-
tors and biologic agents may reduce the symptoms associated 
with IBD and achieve long-term remission, and also therapy 
may be modified to some extent based on the severity, dis-
ease location, extraintestinal manifestations, and associated 
complications.10
Materials and methods
A critical review was performed by defining a scope review 
and collect relevant data sources and review literature, the 
application of literature to the current study.11 Electronic data-
bases such as PubMed, Google Scholar, and relevant Journals 
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Abstract
Objective Many dietary and lifestyle factors are found to be associated with the pathogenesis of inflammatory bowel disease (IBD). The 
purpose of this study is to review the dietary and lifestyle factors associated with IBD. In addition too, this review attempts to investigate 
the association between dietary patterns and IBD risk and compare lifestyle factors among IBD patients.
Methods Google Scholar and PubMed were searched together with relevant journals for English studies from September 2018 to August 
2020. The original studies which evaluated the lifestyle factors and dietary patterns as risk factors for inflammatory bowel disease were 
included.
Results Several studies in IBD were discussed, and highlighted the independent effects of various dietary and lifestyle factors on the 
risk of IBD. Forty-nine (49) articles met the inclusion criteria and indicated that dietary factors tend to play a pivotal role in the disease 
etiopathogenesis and course. However, research on food and IBD is contradictory.
Conclusions An excessive intake of sugar and animal fat is considered a risk factor for the development of IBD, whereas a high fiber diet and 
high intake of fruits and vegetables may play a protective effect. The role of lifestyle factors in IBD is crucial. Amply of evidence suggested 
that smoking is a causative agent in Crohn’s disease while it is protective against ulcerative colitis. Stress, depression, vitamin D deficiency, 
and impaired sleep have all been all associated with incident IBD. A diet with a modified carbohydrate composition, a semi-vegetarian diet, 
a diet low in protein and fat, and a diet low in fermentable oligosaccharides, disaccharides, monosaccharides and polyols should be taken 
into consideration for IBD patients.
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were systematically searched for English language publications 
from September 2018 to August 2020. The inclusion criteria 
were: (1) Studies concerning IBD (including Crohn’s disease 
(CD) and ulcerative colitis) diagnosed using any well-estab-
lished criteria. (2) Studies examining quality of life. (3) Studies 
with adult populations; controlled studies, including random-
ized controlled trials (baseline data only), with prospective, 
retrospective, or cross-sectional designs. (4) Peer-reviewed 
papers. (5) Studies focusing on other psychological variables 
such as depression, anxiety, distress, coping, or personality, 
and lifestyle factors like smoking and physical activity. Articles 
with interventional studies (e.g., medication trials); studies 
in languages other than English; conference abstracts or any 
short papers with incomplete data presented; case reports, 
case series, or qualitative research and animal studies were 
excluded.
Titles and abstracts were screened by two authors (TQ 
and RT) for possible inclusion in the study following the 
Preferred Reporting Items for Systematic Reviews and Meta-
Analyses (PRISMA) guidelines.12 Appropriate studies were 
assessed with regards to the inclusion and exclusion crite-
ria. Full texts of selected studies were carefully shortlisted 
regarding the eligibility criteria and methodological aspects. 
Original articles investigated the lifestyle factors and dietary 
patterns as risk factors for IBD were included. After reviewing 
the full texts, all authors were involved in analysis and reach-
ing consensus on the factors emerging from the data. The data 
extraction included authors, year of publication, country of 
origin, design, setting, participant characteristics (IBD sub-
type, age, sex, disease activity status) and sample size, outcome 
measures, and results for main outcome measures.
Results
Of the 786 studies identified during the database searches, 205 
were removed as duplicates. Titles and abstracts were screened 
for the remaining 581 papers, and 346 did not meet the inclu-
sion criteria, leaving 217 included for full review. A total of 49 
unique studies were included in the final review by reading 
a full text. Fig. 2 shows the paper selection process based on 
PRISMA 2009 flowchart.12
Inflammatory bowel disease and 
body mass index
The relationship between body mass index (BMI) and prob-
lems associated with IBD, such as morbidity, complications, 
prognosis, the stage of the disease, and medical therapy, have 
been found in many studies. One study revealed that in IBD 
patients, BMI was lower than that in non-IBD controls.13 
Another study indicated that ulcerative colitis (UC) patients 
have higher BMI than controls or have a BMI in the normal 
range.14 Other studies showed that BMI was decreased in 
patients with active UC, but not in patients with CD, com-
pared with healthy controls.15
On the contrary, others found that patients with inactive 
CD had a lower body weight and BMI value when compared 
with both UC and healthy controls.16 Few studies have shown 
that medical therapy may decrease lean mass.17,18 Another 
study indicated that patients’ BMI is lower than controls before 
the use of therapy.19 Dong et al. (2015) found that medical 
therapy, including corticosteroid, azathioprine, mesalamine, 
and TNF-alpha antagonists, may improve BMI in patients 
with CD. However, the authors found that without therapy, 
Crohn’s patients’ BMI was significantly lower than non-IBD 
controls, while with medical treatment, the difference was not 
statistically significant.14
Obesity may contribute to IBD development through 
several mechanisms. IBD was found to be associated with 
excess adipocyte hypertrophy generating a pro-inflamma-
tory state through secretion of inflammatory cytokines and 
chemokines, including interleukin (IL)-1β, IL-6, IL-8, mono-
cyte chemoattractant factor (MCP-1), tumor necrosis factor-α 
(TNF- α), and C-reactive protein; CRP.15 These biofactors are 
closely related to the pathogenesis of IBD.15 Epidemiological 
studies have shown a parallel rise in the prevalence of obesity 
and immune-mediated conditions, including IBD. This asso-
ciation may produce a host pro-inflammatory response that 
originates from adipokines produced by visceral and subcuta-
neous fat.15,20 Reduced level of adiponectin plays a permissive 
role in the release of pro-inflammatory cytokines (TNFα; CRP; 
interleukin-6: IL-6; vascular cell adhesion molecule-1: VCAM 
1; and MCP-1), additionally, insulin resistance is promoted 
by the interaction of TNFα and insulin receptor through a 
decrease in tyrosine kinase, and this promotes oxidative stress 
which can impact intestinal bacteria.21 Moreover, alterations 
in the intestinal microbiome contribute to dysbiosis as well 
as to altered intestinal permeability which then, in turn, con-
tributes to promoting the pro-inflammatory state like IBDs.20 
Fig. 3 shows the effect of obesity on the development of IBD.20
Mendall et al. (2011) documented that there was a signif-
icant association between obesity at diagnosis for CD but not 
with UC in their case–control study for IBD patients attend-
ing gastroenterology clinics. Their study aimed to determine 
whether obesity at diagnosis is a risk factor for CD and UC 
versus community controls and whether there is a U-shaped 
relationship between BMI at diagnosis and risk of CD versus 
UC. The authors revealed that obesity at diagnosis was more 
common in subjects with CD versus UC with an odds ratio of 
2.02 (1.18–3.43) p = 0.0096 and also CD versus community 
controls in the 50–70 year age group (odds ratio 3.22 (1.59–
6.52) p=0.001).22 There was evidence of a ‘dose–response’ 
Fig. 1 The complex pathogenesis of inflammatory bowel diseases 
(IBD).3
Abbreviations: NGS (Next Generation Sequencing), WGS (Whole Genome 
Sequencing), WES (Whole Exome Sequencing), GWAS (Genome-Wide 
Association Studies) and MiRNAs (Micro Ribonucleic Acids).
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phenomenon with increasing degrees of obesity-associated 
with increased disease risk. Low BMI at diagnosis was also 
associated with the risk of CD versus UC. A U-shaped rela-
tionship between BMI and risk of Crohn’s was supported by 
the strong inverse association of BMI at diagnosis (p=0.0001) 
and positive association of BMI at diagnosis squared (p = 
0.0002).22 However, another hypothesis of the relationship 
between obesity and IBD was reported by Chan et al. (2013), 
they found out that there was no association with the four 
higher categories of BMI compared with a normal BMI for 
UC (P trend=0.36) or CD (P trend=0.83). The lack of associ-
ation was consistent when BMI was analyzed as a continuous 
or binary variable (BMI 18.5<25.0 vs. ≥ 25 kg/m2), they con-
cluded that obesity, as measured by BMI, is not associated with 
the development of incident UC or CD.23
Inflammatory bowel disease 
and malnutrition
Nutrition plays a pivotal role in the clinical care of patients with 
IBD. In broad terms, nutritional therapy can be considered as 
supportive or even a primary treatment. Supportive therapy 
aims to correct malnutrition and micronutrient deficiencies 
and reverse their metabolic pathological consequences, in 
addition to providing advice on specific dietary regimes.24 
Patients with IBD often suffer from nutritional deficiencies. 
Malnutrition is characterized by weight loss, growth failure, 
and micronutrient depletion.24 A study by Nguyen et al. (2008) 
examined the prevalence of clinically diagnosable malnutri-
tion among hospitalized patients with IBD in the United States 
and whether this malnutrition influenced health outcomes. 
The authors revealed that the prevalence of malnutrition was 
greater in CD and UC patients than in non-IBD patients (6.1% 
and 7.2% vs 1.8%, p<0.0001). The adjusted odds ratio for mal-
nutrition among IBD admissions compared with non-IBD 
admissions was 5.57 [95% CI: 5.29–5.86]. Additionally, there 
was an increased likelihood of malnutrition among those with 
fistulizing CD (OR 1.65; 95% CI: 1.50–1.82) and those who 
had undergone bowel resection (OR 1.37; 95% CI: 1.27–1.48). 
Malnutrition was associated with increased in-hospital mor-
tality (OR 3.49; 95% CI: 2.89–4.23). This study suggests that 
malnutrition may serve as a clinical marker of poor IBD prog-
nosis in hospitalized patients.25
Inflammatory bowel disease and physical activity
Physical activity may play a role in reducing the risk of diver-

















Fig. 2. The paper selection process based on Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses PRISMA 2009 flowchart.12 
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bowel disease.26 Current research revealed that exercise may 
be beneficial to reduce stress and symptoms of IBD, and also 
recommends exercise to help counteract some IBD specific 
complications by improving bone mineral density, immuno-
logical response, psychological health, weight loss, and stress 
management ability.27
A host of environmental factors may contribute to the 
onset of IBD. Several studies examined the role of physical 
activity and active lifestyle as potential protective factors in 
the development of IBD. Ng et al. (2015) found a protective 
effect of exercise and onset of CD (OR: 0.58; 95% CI: 0.4–1.0), 
but none for UC, when comparing 186 CD patients, 256 UC 
patients and 940 controls matched for age, sex, and geograph-
ical location.28 A case–control study in a Slovakian population 
found a statistically significant association between lower 
weekly rates of sport participation among adolescent and the 
development of IBDs (OR: 2.7, 95% CI: 1.5–5.0).29 However, 
Chan et al. (2013) found in a prospective cohort study of 
177 UC and 75 CD patients that there was no association 
between physical activity levels and UC, (P-trend=0.79) or CD 
(P-trend=0.42) 23.
Inflammatory bowel disease and lifestyle factors
The role of lifestyle factors in IBD is crucial. Smoking was first 
established as a risk factor in the development of IBD more 
than 30 years ago.30 Smoking is one of the most important and 
well-characterized environmental risk factors for IBD, but its 
pathogenic mechanism is not clear. Evidence from studies 
suggested that smoking is a causative agent in CD while it is 
protective against UC.31,32 The association between smoking 
and UC was first described by Harries et al. (1982) who noted 
a reduced frequency of smokers among patients with UC 
compared to healthy controls.30 The effect of smoking on the 
localization and clinical course of 231 patients with CD was 
studied by Lindberg et al. (1992) who found that heavy smok-
ers (greater than 10 cigarettes/d) had small bowel CD more 
Fig. 3 The effect of obesity on developing Inflammatory Bowel Disease (IBD).20 
Abbreviations: TNFα (Tumor Necrosis Factor-alpha), CRP (C - reactive protein), VACAM-1 (Vascular Cell Adhesion 
Molecule-1), IL-6 (Interleukin-6) and MCP-1 (Monocyte Chemoattractant Protein-1).
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often than patients that smoked (less than 10 cigarettes/d) (p 
= 0.045).33 Van der Heide et al. (2009) found that no detri-
mental effects of active smoking on CD were observed, but 
passive smokers had higher need of immunosuppressant and 
infliximab-based therapy more frequently than non-passive 
smokers. Additionally, the authors found that active smoking 
had beneficial effects on UC, indicated by reduced rates of col-
ectomy, primary sclerosing cholangitis, and backwash-ileitis 
in active smokers compared to never smokers.34 Furthermore, 
Cosnes et al. (1999) found that early smoking significantly 
increases the risk of CD [OR 2.0 (1.65–2.47)], also CD patients 
who smoke had a worse course of illness and quality of life, 
and were more likely to develop complications. Additionally, 
they had a higher rate of hospitalizations, showed a worse 
response to treatments, and had a greater need for surgery.35
The mechanisms of the effect of smoking in IBD are com-
plex, involving different chemicals found in the cigarette, such 
as nicotine, free radicals, and carbon monoxide, that can act 
on different targets, including mucus layer, cytokine produc-
tion, macrophage function, and microvasculature.36
Both smoking and nicotine affect the cytokine profile, 
predominantly by reducing the production of proinflamma-
tory cytokines. Smokers with active inflammatory bowel dis-
ease have significantly lower concentrations of IL-1β and IL-8 
in patients with UC, and IL-8 in patients with CD than in 
non-smokers.37 Other evidence suggested that in patients with 
CD, when a high concentration of cigarette particulate matter 
reaches the ileum, it may alter the interaction of the intestinal 
mucosa with the microbiota through several mechanisms, e.g., 
affecting bacterial clearance, changing microbiota composition, 
increasing the permeability of the intestinal barrier, and dysreg-
ulating immune responses.32 On the contrary, people who have 
UC have a thinner mucus layer in the left colon and rectum 
when compared to healthy people. Thus, it has been proposed 
that nicotine may increase the production of mucus and sup-
press the immune system which subsequently prevents inflam-
mation in the colon.37 Another theory states that nitric oxide, 
released by nicotine, may reduce muscle activity in the colon.39
Many other lifestyle factors are likely to enhance the 
risk of developing IBD. Stress reduces mucus secretion and 
increases intestinal permeability of colon in a mouse model.40 
Bitton et al. (2008) documented the association between 
major life stress factors, anxiety, depression, and IBD risk. The 
authors showed that participants with higher stress suffered 
from more relapses of both UC and CD. Also, the presence of 
anxiety or depression has been associated with increased dis-
ease activity and an increased risk of surgery in CD patients.41
Inflammatory bowel disease and 
dietary patterns
Diet was suspected to be an environmental factor involved in 
the etiology of IBD.42 Experimental models showed that diet 
contributed to gut inflammation through several mechanisms 
including antigen presentation, alteration of gut permeability, 
and changes in the composition of the gut microbiota.42-44
The Mediterranean diet has long been accepted as 
an example of a well-balanced diet but a gold-standard 
“Mediterranean diet” is lacking.45 At least 16 countries bor-
der the Mediterranean Sea, variation in Mediterranean diet 
among these countries as well as among regions within the 
same country is well known.46 However, despite the above 
variation, a Mediterranean diet has the following common 
characteristics: high consumption of fruits, vegetables, bread, 
other cereals, potatoes, beans, nuts, and seeds; low to moder-
ate consumption of dairy products, fish, eggs, and poultry; and 
infrequent consumption of red meat.47 In the Mediterranean 
diet, olive oil is frequently consumed which is an important 
monounsaturated fat source and wine is consumed in low 
to moderate amounts as well.48 The combination and range 
of foods included in this dietary pattern provide plenty of 
antioxidants such as flavonoids, carotenoids, and antioxidant 
vitamins, lots of phytochemicals including phytoestrogens, 
sufficient quantities of fiber, adequate folate, and a favorable 
fatty acid profile.45 A growing body of scientific evidence indi-
cated that the Mediterranean dietary pattern was associated 
with significant improvements in health status and a decrease 
in inflammatory markers.47,49
The protective effect of the Mediterranean diet was 
hypothesized to be derived from the balance in the omega-6/
omega-3 ratio of the Mediterranean diet pattern (35% total 
fat: 15% monounsaturated fatty acids (MUFA) (mainly from 
olive oil), 13% saturated fatty acids (SFA), and 6% polyun-
saturated fatty acids (PUFA).50 Additionally, adherence to 
the Mediterranean diet pattern has been shown to benefi-
cially affect the gut microbiome and gut metabolites (metab-
olome).51 Also, there was a large body of evidence showing 
that Mediterranean dietary patterns regulate inflammation 
in chronic disease.51,52 A case–control study (n = 264 IBD 
subjects and 203 controls) found that low adherence to the 
Mediterranean dietary pattern was a significant risk factor in 
the development of pediatric UC (OR: 2.3; CI: 12–4.5).51
In addition, other dietary patterns were found to be asso-
ciated with the risk of IBD, such as Western dietary pattern 
which is high in meat, dairy products, fat, sugary foods, pro-
cessed meats, pastries, baked goods, confectionery, sweet-
ened drinks, alcohol, and limited amounts of vegetables and 
fruits.9 IBD has traditionally been thought of as a disease 
of the Western hemisphere, however, there is an increased 
incidence in Japan, Hong Kong, Korea, and Eastern Europe, 
although still not as common, an increasing incidence of IBD 
is identified in South Africa, South America, and Saudi Arabia 
as well.53 The dramatic rise in the incidence of IBD, particu-
larly in South Asia, India, and Japan, traditionally low inci-
dence countries, suggested that environmental factors, such as 
Western dietary pattern, may play an important role in dis-
ease pathogenesis.28 Migration from a low incidence country 
to a high incidence country increases the risk of developing 
IBD.54 A Western diet that contains pro-inflammatory food 
cytokines, can modulate intestinal permeability, and alter the 
intestinal microbiota promoting a low-grade chronic inflam-
mation in the gut which is considered an important risk factor 
and a prerequisite in the development of UC.54 A case–con-
trol study conducted in Iran on newly diagnosed UC patients 
(n = 62 UC patients, 124 controls) showed that subjects that 
had a higher dietary inflammatory index (pro-inflammatory 
diet) had an increased risk of developing UC (OR: 1.55, 95% 
CI: 1.04–2.32.55 Shivappa et al. (2016) concluded that encour-
aging intake of more anti-inflammatory dietary factors, such 
as plant-based foods rich in fiber and phytochemicals, and 
reducing intake of pro-inflammatory factors, such as fried or 
processed foods rich in transfatty acids, could be a potential 
strategy for reducing the risk of UC.55 A meta-analysis showed 
an inverse association between the intake of vegetables and 
fruit and CD, with a pooled OR for the highest versus lowest 
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consumption of fruit = 0.57(95% CI 0.44–0.74).56 However, 
patients who consumed a pro-inflammatory diet (e.g., high 
in animal protein, low in fruit and vegetables) have demon-
strated a higher risk of ulcerative colitis.56
A prospective trial conducted in Japan in hospitalized 
subjects with CD (n=22) examined the effect of a semi-vege-
tarian diet on maintaining remission. The diet was Lacto-Ovo 
vegetarian, in which eggs and milk were allowed with small 
portions, meat offered once every 2 weeks and fish weekly. 
The remission rate, a period which symptoms of disease were 
reduced or disappeared, achieved with the semi-vegetarian 
diet was 100% after 1 year and 92% after 2 years. A semi-vege-
tarian diet showed significant prevention of relapse (p = 0.003 
log-rank test). Based on these observations, the semi-vegetar-
ian diet may be a highly effective way to maintain a remis-
sion CD.57 Furthermore, the rise in the incidence of IBD in 
countries that had a very low incidence suggested that indus-
trialization and adoption of the westernized diet may be a 
risk factor in the development of IBD, additionally reduced 
consumption of fruits and possibly vegetables, resulting in a 
reduced overall intake of fiber, with higher intake of meats, fast 
foods, and transfatty acids appeared to be associated with an 
overall increase in the risk of developing IBD.58
A case–control study carried out by Sakamoto et al. (2005) 
revealed that a higher consumption of sweets was positively 
associated with UC risk [OR for the highest vs lowest quartile, 
2.86; 95% CI, 1.24–6.57], whereas the consumption of sugars 
and sweeteners (OR, 2.12; 95% CI, 1.08–4.17), sweets (OR, 
2.83; 95% CI, 1.38–5.83), fats and oils (OR, 2.64; 95% CI, 1.29–
5.39), and fish and shellfish (OR, 2.41; 95% CI, 1.18–4.89) were 
positively associated with CD risk. For nutrients, the intake 
of vitamin C (OR, 0.45; 95% CI, 0.21–0.99) was negatively 
related to UC risk, while the intake of total fat (OR, 2.86; 95% 
CI, 1.39–5.90), MUFAs (OR, 2.49; 95% CI, 1.23–5.03) and 
polyunsaturated fatty acids (OR, 2.31; 95% CI, 1.12–4.79), 
vitamin E (OR, 3.23; 95% CI, 1.45–7.17), and n-3 fatty acids 
(OR, 3.24; 95% CI, 1.52–6.88) and n-6 fatty acids (OR, 2.57; 
95% CI, 1.24–5.32)  were positively associated with CD risk.59 
Geerling et al. (2000) found that high intakes of monounsat-
urated fat (OR: 33.9 [95% CI 2.6–443.1]), polyunsaturated fat 
(OR: 5.1 [95% CI 1.0–26.7]), and vitamin B6 (OR: 6.9 [95% 
CI 1.6–30.7] were associated with an increased risk to develop 
UC.60 In a case–control study conducted in Jordan by Rayyan 
et al. (2021), the authors showed that IBD patients showed sig-
nificant increase in the intake of saturated fat, protein, carbo-
hydrates, sugars, fiber, MUFA, trans-fat cholesterol, vitamins 
A, D, E, B12, C and folate, beta-carotene, retinol, calcium, 
potassium, iron, Omega-3 and Omega-6 compared to the con-
trol group. However, the control group showed higher intake 
of vitamin K and caffeine when compared to the IBD patients 
(p < 0.05).61
Conclusion
In this review, we found that IBD is chronic relapsing intestinal 
inflammatory disease characterized by complex interactions of 
multiple factors including smoking, major life stressors, diet, 
and lifestyle.  Various dietary and nutritional factors have been 
suggested as being significant etiological factors both for CD 
and UC. However, research on food and IBD is contradictory. 
An excessive intake of sugar and animal fat is considered a risk 
factor for the development of IBD, whereas a high fiber diet 
and high intake of fruits and vegetables may play a protective 
effect.  The role of lifestyle factors in IBD is crucial. Amply of 
evidence suggested that smoking is a causative agent in CD 
while it is protective against UC. Stress, depression, vitamin 
D deficiency, and impaired sleep have all been all associated 
with incident IBD. A diet with a modified carbohydrate com-
position, a semi-vegetarian diet, a diet low in protein and fat, 
and a diet low in fermentable oligosaccharides, disaccharides, 
monosaccharides, and polyols should be taken into consider-
ation for IBD patients.
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